USFDA completes audit at MSN Pharma with zero observations

USFDA completes audit at MSN Pharma with zero observations

Picture: Pixabay

Last Updated on December 23, 2021 by The Health Master

The company was notified via a statement that MSN Pharmaceuticals Inc. has completed its maiden US Food and Drug Administration (USFDA) audit with zero observations.

The dosage facility was established to bolster MSN Group’s product portfolio as well as contract development and manufacturing services, in the US and several other key regulatory markets, the statement said.

Govt approves PLI scheme to promote domestic API production

Govt is working on policy to encourage research in Pharma sector

Pharmexcil to organize seminar on ‘Reinvigorating India’s Pharma Exports’

BDR Pharma launches generic Pazopanib to treat these diseases

Haryana is the best state for setting up Pharma Industries: HM

Medical Devices: Current scenario and need of the hour

Govt notifies NIB, Noida as CDL to test Covid-19 vaccines

FDA Haryana and police unearthed a unit manufacturing spurious cosmetics

Recruitment of 87 Drug Inspectors put on hold in Maharashtra

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner